drugset
drugset / Trial / NCT06256445

Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area

NCT06256445 ↗

Phase 3 Completed 252 enrolled AMIpharm Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate Efficacy and Safety of AYP-101 S.C injection for the Reduction of Submental Fat in Adults

Timeline

Start
2024-03-26
Primary completion
2024-07-05
Completion
2025-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Polyene Phosphatidylcholine Small molecule 25 mg/ml Subcutaneous

Indications

No indication recorded.